Search results
RNA editing with CRISPR - Nature Genetics
Nature· 4 days agoCRISPR-mediated selective DNA cleavage has revolutionized gene editing, but analogous methods to manipulate RNA, thus preserving the genome and avoiding potential adverse ...
H.C. Wainwright lowers Applied DNA Sciences shares target amid share dilution By Investing.com
Investing.com· 6 days agoOn Monday, H.C. Wainwright adjusted its outlook on Applied DNA Sciences (NASDAQ:APDN) shares,...
V Square Quantitative Management LLC Grows Stock Holdings in Illumina, Inc. (NASDAQ:ILMN)
ETF DAILY NEWS· 15 hours agoThe institutional investor owned 3,466 shares of the life sciences company’s stock after purchasing an additional 1,239 shares during the quarter. V Square Quantitative Management ...
Inside the Human Brain: Genetic Discoveries That Could Revolutionize Medicine
SciTechDaily· 5 days agoNew study could improve the ability to make genetic diagnoses and treat neurodevelopmental...
Dysfunctional enzyme may lead to liver disease, research suggests
Medical Xpress· 3 days agoA dysfunctional enzyme may lead to nonalcoholic fatty liver disease in mice, according to a study...
QIAGEN (QGEN) Unveils dPCR Tool, Enhances GeneGlobe Platform
Zacks via Yahoo Finance· 6 days agoOther Developments in the Life Sciences Business Last month, QIAGEN launched the QIAseq Multimodal...
How personalized cancer vaccines could keep tumours from coming back
Nature· 6 days agoThe same mRNA technology that quickly brought the world a vaccine for COVID-19 is now showing...
Skyhawk Therapeutics Promotes Clint Musil to Chief Executive Officer and Appoints Co-founder Bill...
Benzinga· 5 days agoSkyhawk Therapeutics, Inc., a clinical-stage biotechnology company developing novel small molecule therapies designed to modulate critical RNA targets, today announced the ...
The 7 Best Vitamins & Supplements for ED
MediaFeed via AOL· 6 days agoIn this study, men with ED showed measurable improvements in erectile function after taking a vitamin B9 supplement on a daily basis for three months....
Toronto genomics company expands to Cambridge - Boston Business Journal
The Business Journals· 2 days agoIn 2021, with $180 million of Series C funding and expansion ideas, Toronto-founded Deep Genomics...
